Enhancement of neuroprotection of mulberry leaves (Morus alba L.) prepared by the anaerobic treatment against ischemic damage

Biological and Pharmaceutical Bulletin

Volumn 29, Issue 2, 2006, Pages 270-274

  Tong, Ho Kang ^a   Hye, Rim Oh ^a   Sun, Moon Jung ^a   Jong, Hoon Ryu ^a   Mee, Won Park ^b   Yong, Kon Park ^b   Sun, Yeou Kim ^a  

^a Kyung Hee University   (South Korea)

^b Korea Food Research Institute   (South Korea)

Author keywords

Anaerobic treatment; Cerebral ischemia; Mulberry leaf; Neuroprotection; aminobutyric acid (GABA)

Indexed keywords

4 AMINOBUTYRIC ACID; GLUCOSE; HYDROGEN PEROXIDE; MORUS ALBA EXTRACT; NEUROPROTECTIVE AGENT; NITROGEN; OXYGEN; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION SIZE; BRAIN INJURY; BRAIN ISCHEMIA; CELL STRAIN; CONTROLLED STUDY; CYTOTOXICITY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; MULBERRY; NEUROPROTECTION; NONHUMAN; OXIDATION; PH; PLANT LEAF; RAT; REACTION TIME; STATISTICAL SIGNIFICANCE; TEMPERATURE;

EID: 32044475400     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.29.270     Document Type: Article

References (23)

1. Chen F., Nakashima N., Kimura I., Kimura M., Yakugaku Zasshi, 115, 476-482 (1995).
2. Asano N., Tomioka E., Kizu H., Matsui K., Carbohydr. Res., 253, 235-245 (1994).
3. Kim S. Y., Gao J. J., Lee W. C., Ryu K. S., Lee K. R., Kim Y. C., Arch. Pharm. Res., 22, 81-85 (1999).
4. Lee S. H., Choi S. Y., Kim H., Hwang J. S., Lee B. G., Gao J. J., Kim S. Y., Biol. Pharm. Bull., 25, 1045-1048 (2002).
5. Yamashita T., Tree Physiol., 6, 191-200 (1990).
6. Sherif F. M., Ahmed S. S., Clin. Biochem., 28, 145-154 (1995).
7. Weiner M. F., Speciale S. G., Risser R. C., Kramer G. L., Petty F., Biol. Psychiatry, 40, 933-934 (1996).
8. Zhao P., Qian H., Xia Y., Eur. J. Neurosci, 22, 289-300 (2005).
9. Gunawan S., Walton N. Y., Treiman D. M., J. Chromatogr., 503, 177-187 (1990).
10. Koh J. Y., Choi D. W., J. Neurosci. Methods, 20, 83-90 (1987).
11. Hansen M. B., Nielsen S. E., Berg K., J. Immunol. Methods, 119, 203-210 (1989).
12. Kilic E., Bahr M., Hermann D. M., Stroke, 32, 2641-2647 (2001).
13. Bederson J. B., Pitts L. H., Germano S. M., Nishimura M. C., Davis R. L., Bartkowski H. M., Stroke, 17, 1304-1308 (1986).
14. Lin T. N., He Y. Y., Wu G., Khan M., Hsu C. Y., Stroke, 24, 117-121 (1993).
15. Jayakumar A. R., Sujatha R., Paul V., Asokan C., Govindasamy S., Jayakumar R., Brain Res., 837, 229-235 (1999).
16. Chandra J., Samali A., Orrenius S., Free Radic. Biol. Med., 29, 323-333 (2000).
17. Gao H. B., Guo S. R., Zhi Wu Sheng Li Yu Fen Zi Sheng Wu Xue Xue Bao, 30, 651-659 (2004).
18. Siesjo B. K., J. Neurosurg., 77, 337-354 (1992).
19. Mattson M. P., Duan W., Pederson W. A., Culmsee C., Apoptosis, 6, 69-81 (2001).
20. Park Y. J., Koketsu M., Kim J. M., Yeo J. H., Ishihara H., Lee K. G., Kim S. Y., Kim C. K., Biol. Pharm. Bull., 26, 1657-1660 (2003).
21. MacKenzie E. T., Duverger D., Gotti B., Nowieki J. P., "Pharmacology of Cerebral Ischemia," Elsevier, Amsterdam, 1986, pp. 167-179.
22. Madden K., Stroke, 25, 2271-2274 (1994).
23. Johanson F. F., Diemer N. H., Acta Neurol. Scand., 84, 1-6 (1991).